Institutional investors hold a majority ownership of SGEN through the 105.18% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2015, these large investors purchased a net $177.4 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAKER BROS. ADVISORS LP Bought 2.0 Million shares of Seattle Genetics Inc
FIRST TRUST ADVISORS LP Bought 1.3 Million shares of Seattle Genetics Inc
T. ROWE PRICE ASSOCIATES, INC. Bought 1.2 Million shares of Seattle Genetics Inc